Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.
In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.Call us
For general enquiries call us on one of the numbers below.
United Arab Emirates: (+971 4 403 7159)
Report an adverse event
To report an adverse event either:
A) Send an email to:
B) Click on the link below.
Latest GSK news and updates
Take control of how you receive emails from GSK
GSK may monitor our technology tools and services (including email, phone, and other communications sent to and from GSK) to maintain the security of systems, and to protect our staff, customers and business partners from cyber threats and loss of information. Examples of these monitoring activities include checks for offensive materials, viruses and other malignant code, and unauthorized or unlawful activity.
You can learn about the information that we may process about you, and how we use your information, here.
For more information, please refer to the prescribing information or contact GlaxoSmithKline via gcc.medinfo@gsk.com
To report Adverse Event/s associated with the use of GSK product/s, please contact us via
gulf.safety@gsk.com
To report quality complaint/s associated with the use of GSK product/s, please contact us via
Gulf.ProductQualityComplaints@gsk.com
Department of Pharmacovigilance |
دائرة التيقظ الدوائي مركز سلامة الدواء وزارة الصحة،سلطنة عمان 0096822357660 / 0096822357686 :هاتف 0096822357626 / 0096822357900 pharma-vigil@moh.gov.om :البريد الالكتروني www.moh.gov.om :الموقع الالكتروني |
Availability of GSK products varies by market. For registered products in your country, refer to the local prescribing information for details.
